What should nurses know about treating patients with KRAS G12C-mutated metastatic colorectal cancer using adagrasib and cetuximab?
December 2025
A patient acuity model drove efficient and safe staffing through data from a natural language processing model informed by oncology nurse insights.
With evolving standards for handling hazardous drugs, nurses must comply with safety and handling guidelines.
The FDA has granted approval to adjuvant cemiplimab treatment for patients with high-risk cutaneous squamous cell carcinoma after surgery and radiation.
The FDA has approved imlunestrant for the treatment of patients with ESR1-mutated ER+, HER2- metastatic breast cancer.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC
2
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
3
Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma
4
Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer
5
